We are live on ! Find out more
NCM

Novare Capital Management Portfolio holdings

AUM $1.41B
1-Year Est. Return 25.38%
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
+25.38%
3 Year Est. Return
+76.47%
5 Year Est. Return
+92.66%
10 Year Est. Return
+281.33%
AUM
$1.33B
AUM Growth
+$21.4M
Cap. Flow
-$14.1M
Cap. Flow %
-1.05%
Top 10 Hldgs %
36.74%
Holding
207
New
14
Increased
83
Reduced
75
Closed
12

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$7.62M
2
ZTS icon
Zoetis
ZTS
+$6.41M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$5.56M
4
ADBE icon
Adobe
ADBE
+$2.82M
5
ACN icon
Accenture
ACN
+$2.11M

Sector Composition

Rank Sector Weight
1 Technology 22.55%
2 Industrials 10.6%
3 Financials 10.2%
4 Healthcare 9.13%
5 Communication Services 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
26
Cisco
CSCO
$488B
$15M 1.12%
194,660
-688
-0.4% -$51K
TMO icon
27
Thermo Fisher Scientific
TMO
$221B
$14.7M 1.1%
25,376
+101
+0.4% +$57.1K
AME icon
28
Ametek
AME
$58B
$14.4M 1.08%
70,168
-499
-0.7% -$97.1K
GSLC icon
29
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$16B
$14.3M 1.07%
108,338
+1,777
+2% +$233K
META icon
30
Meta Platforms (Facebook)
META
$1.52T
$14.2M 1.07%
21,585
-579
-3% -$387K
CHRW icon
31
C.H. Robinson
CHRW
$17.5B
$14.2M 1.07%
88,473
-5,711
-6% -$844K
SYK icon
32
Stryker
SYK
$132B
$13.6M 1.02%
38,571
+3,134
+9% +$1.14M
ABT icon
33
Abbott
ABT
$188B
$13.1M 0.98%
104,349
+1,294
+1% +$165K
ABBV icon
34
AbbVie
ABBV
$434B
$13M 0.97%
56,841
-838
-1% -$191K
LHX icon
35
L3Harris
LHX
$54.1B
$12.8M 0.96%
43,571
-780
-2% -$225K
AMP icon
36
Ameriprise Financial
AMP
$49.3B
$12.6M 0.94%
25,602
+160
+0.6% +$75.9K
MRK icon
37
Merck
MRK
$322B
$11.9M 0.89%
113,106
+1,322
+1% +$124K
HD icon
38
Home Depot
HD
$348B
$11.8M 0.88%
34,314
-8
-0% -$2.93K
AMLP icon
39
Alerian MLP ETF
AMLP
$13.2B
$11.6M 0.87%
247,500
+7,425
+3% +$348K
LOW icon
40
Lowe's Companies
LOW
$122B
$11.6M 0.87%
48,226
+613
+1% +$147K
HON icon
41
Honeywell
HON
$76.9B
$11.3M 0.85%
57,990
-3,932
-6% -$769K
MOAT icon
42
VanEck Morningstar Wide Moat ETF
MOAT
$12.3B
$11M 0.83%
106,560
+414
+0.4% +$42.3K
BAC icon
43
Bank of America
BAC
$446B
$10.9M 0.82%
198,561
+2,167
+1% +$115K
ICE icon
44
Intercontinental Exchange
ICE
$84.7B
$10.8M 0.81%
66,946
+1,255
+2% +$197K
CSX icon
45
CSX Corp
CSX
$92.8B
$10.8M 0.81%
298,850
+1,179
+0.4% +$42.2K
QQQ icon
46
Invesco QQQ Trust
QQQ
$480B
$10.2M 0.77%
16,635
-619
-4% -$380K
IVW icon
47
iShares S&P 500 Growth ETF
IVW
$77.6B
$9.95M 0.75%
80,746
-2,695
-3% -$330K
TXN icon
48
Texas Instruments
TXN
$258B
$9.56M 0.72%
55,095
-271
-0.5% -$46.4K
CVX icon
49
Chevron
CVX
$381B
$9.54M 0.72%
62,608
+335
+0.5% +$51K
IJH icon
50
iShares Core S&P Mid-Cap ETF
IJH
$127B
$9.5M 0.71%
143,940
+1,969
+1% +$129K

Similar funds

Novare Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Novare Capital Management held 207 positions worth $1.33B, up 1.6% from $1.31B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Novare Capital Management's Q4 2025 filing shows 14 new, 83 increased, 75 reduced and 12 closed positions. Its largest new stake was Akre Focus ETF: 8,351 shares worth $547K. The largest sale was Kenvue, an estimated $7.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Financials.

  • Novare Capital Management's largest Q4 2025 buy was Akre Focus ETF: 8,351 shares worth $547K.
  • Novare Capital Management added most to Visa in Q4 2025, an estimated $7.37M increase.
  • Novare Capital Management's biggest Q4 2025 reduction was Kenvue, cutting an estimated $7.62M.
  • Novare Capital Management fully exited Vanguard S&P 500 Growth ETF in Q4 2025, selling an estimated $1.07M.
  • Novare Capital Management's ten largest holdings make up 37% of its $1.33B portfolio in Q4 2025.
  • Novare Capital Management opened 14 new positions and closed 12 in Q4 2025.
  • Novare Capital Management's portfolio value rose 1.6% quarter-over-quarter to $1.33B.

Based on Novare Capital Management's 13F filing for Q4 2025, filed 5 Feb 2026.